The present invention addresses the problem of providing a medicine for preventing or suppressing the survival of cancer cells in a destination tissue. The purpose of the present invention is to provide a medicine for preventing or suppressing the survival of cancer cells in lymphogenous or hematogenous destination tissue, and having an organic acid polymer represented by general formula (I) [(O